Heterogeneity in the phosphorylation of human death receptors by p42mapk/erk2

被引:17
作者
Frankel, SK
Van Linden, AA
Riches, DWH
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
关键词
signal transduction; p42(mapk/erk2); TNF receptor superfamily Fas; CD120a; DR3;
D O I
10.1006/bbrc.2001.5761
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorylation of murine CD120a by p42(mapk/erk2) has been shown to inhibit its ability to initiate apoptosis while preserving signaling events such as NF-(B kappa) activation. Therefore, we sought to determine if p42(mapk/erk2) was also capable of phosphorylating additional human death receptors within the TNF receptor superfamily. These studies showed that CD120a and DR3 are significantly phosphorylated by p42(mapk/erk2) but Fas, DR4 and DR5 are not. Additionally, we demonstrated that (i) the p42(mapk/erk2) -dependent phosphorylation of CD120a and DR3 occurred on Ser and Thr residues, (ii) p42(mapk/erk2) phosphorylated residues located in the membrane proximal regions but not the death i domains of CD120a and DR3, (iii) Ser 253 is a preferred site of phosphorylation on CD120a, and (iv) the p42(mapk/erk2)-dependent phosphorylation of the DRS cytoplasmic domain occurred exclusively at non-p42/44(mapk/erk2/1) consensus sites. These findings suggest that human death receptors segregate into two groups along lines of phylogeny with respect to Ser/Thr phosphorylation by p42(mapk/erk2). (C) 2001 Academic Press.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 32 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   CASEIN KINASE-1 PHOSPHORYLATES THE P75 TUMOR-NECROSIS-FACTOR RECEPTOR AND NEGATIVELY REGULATES TUMOR-NECROSIS-FACTOR SIGNALING FOR APOPTOSIS [J].
BEYAERT, R ;
VANHAESEBROECK, B ;
DECLERCQ, W ;
VANLINT, J ;
VANDENABEELE, P ;
AGOSTINIS, P ;
VANDENHEEDE, JR ;
FIERS, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23293-23299
[3]   TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95) [J].
Bodmer, JL ;
Burns, K ;
Schneider, P ;
Hofmann, K ;
Steiner, V ;
Thome, M ;
Bornand, T ;
Hahne, M ;
Schroter, M ;
Becker, K ;
Wilson, A ;
French, LE ;
Browning, JL ;
MacDonald, HR ;
Tschopp, J .
IMMUNITY, 1997, 6 (01) :79-88
[4]   MEK activity regulates negative selection of immature CD4+CD8+ thymocytes [J].
Bommhardt, U ;
Scheuring, Y ;
Bickel, C ;
Zamoyska, R ;
Hünig, T .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2326-2337
[5]   Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40
[6]   Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway [J].
Chaudhary, PM ;
Eby, M ;
Jasmin, A ;
Bookwalter, A ;
Murray, J ;
Hood, L .
IMMUNITY, 1997, 7 (06) :821-830
[7]   Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 [J].
Chinnaiyan, AM ;
ORourke, K ;
Yu, GL ;
Lyons, RH ;
Garg, M ;
Duan, DR ;
Xing, L ;
Gentz, R ;
Ni, J ;
Dixit, VM .
SCIENCE, 1996, 274 (5289) :990-992
[8]   Phosphorylation of tumor necrosis factor receptor CD120a (p55) by p42mapk/erk2 induces changes in its subcellular localization [J].
Cottin, V ;
Van Linden, A ;
Riches, DWH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) :32975-32987
[9]   Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis [J].
Cottin, V ;
Van Linden, AA ;
Riches, DWH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17252-17260
[10]   Identification of a novel inhibitor of mitogen-activated protein kinase kinase [J].
Favata, MF ;
Horiuchi, KY ;
Manos, EJ ;
Daulerio, AJ ;
Stradley, DA ;
Feeser, WS ;
Van Dyk, DE ;
Pitts, WJ ;
Earl, RA ;
Hobbs, F ;
Copeland, RA ;
Magolda, RL ;
Scherle, PA ;
Trzaskos, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18623-18632